Delivery Order SPE2DE24D0013-SPE2D625F2KHG
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, with an ultimate completion date of August 12, 2025. This delivery order, designated XPRSARS-COV2-10, carries no set-aside designation and represents a procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, including COVID-19,...
- The U.S. Defense Department's Medical Supply Chain division awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 22, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a discrete procurement action for molecular diagnostic solutions, consistent with Cepheid's core business of manufacturing...
- The U.S. Defense Department's Medical Supply Chain has awarded a $5,082 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2 testing supplies. The contract, awarded on August 4, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation and will be performed at Cepheid's primary facility in Sunnyvale. This delivery order falls under Cepheid's existing indefinite delivery vehicle...
- The U.S. Defense Department's Medical Supply Chain division awarded a $3,850 firm fixed-price delivery order to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. The contract, numbered 4569219084 and designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a discrete procurement under one of Cepheid's existing federal contract vehicles, continuing the...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $23,100 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California. The contract, designated XPRSARS-COV2-10, was executed on August 19, 2025, with an ultimate completion date of August 26, 2025. This delivery order carries no set-aside designation and represents procurement of diagnostic equipment and/or reagents related to COVID-19...
- The Defense Department's Medical Supply Chain division awarded a $9,240 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (4569359243 ! XPRSARS-COV2-10) carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in advanced diagnostic systems and test kits for infectious...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,930.72 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on May 2, 2025, with an ultimate completion date of May 9, 2025. The contract, designated as XPRSMVP-10, carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid specializes in...
- The Defense Department's Medical Supply Chain awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on September 10, 2025, with an ultimate completion date of September 17, 2025. The contract, which carries no set-aside designation, is classified as a delivery order under contract number XPRSARS-COV2-10. Work will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions specializing in advanced diagnostic...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,925 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPRSARS-COV2-10, was executed on July 22, 2025, with a completion date of July 29, 2025, and carries no set-aside designation. This delivery order represents a continuation of the federal government's ongoing procurement of Cepheid's diagnostic testing capabilities, likely...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $9,520 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 13, 2025, and carries no set-aside designation. The contract nomenclature indicates the order pertains to diagnostic testing capabilities for COVID-19, influenza, and respiratory...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2KHGDelivery Order
The Defense Department's Medical Supply Chain agency awarded a $1,540 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 3, 2025, with an ultimate completion date of September 10, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and represents a delivery order likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid specializes in advanced diagnostic systems and test kits, with particular expertise in infectious disease detection including COVID-19, influenza, respiratory syncytial virus, and methicillin-resistant Staphylococcus aureus. This delivery order falls within the scope of Cepheid's established federal contracting relationships, which include two significant IDV vehicles: a $32.8 million single-award contract with VA's Veterans Integrated Service Network 6 covering molecular diagnostic testing system reagents through September 2030, and a $2.5 million contract with VA's Veterans Integrated Service Network 21 focused on PCR testing for laboratory microbiology. The abbreviated contract nomenclature and ceiling value suggest this represents a routine procurement of diagnostic supplies or services supporting the Defense Department's medical supply chain operations, consistent with Cepheid's core business of delivering molecular diagnostic technologies and reagents to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/3/25 |